Free Stock Analysis Report: Buy Sell Hold Predictions on Any Stock
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Analyze Any Stock Free

GNLX Insider Trading

Insider Ownership Percentage: 11.70%
Insider Buying (Last 12 Months): $1,250.00
Insider Selling (Last 12 Months): $5,109,935.98

Genelux Insider Trading History Chart

This chart shows the insider buying and selling history at Genelux by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Genelux Share Price & Price History

Current Price: $24.03
Price Change: Price Decrease of -0.4 (-1.64%)
As of 09/28/2023 01:00 AM ET

This chart shows the closing price history over time for GNLX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Genelux Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/26/2023Yong YuVPSell5,200$23.56$122,512.00106,135View SEC Filing Icon  
9/25/2023Aladar SzalayMajor ShareholderSell12,458$25.77$321,042.661,560,528View SEC Filing Icon  
9/21/2023Aladar SzalayMajor ShareholderSell7,549$28.46$214,844.541,582,028View SEC Filing Icon  
9/20/2023Sean RyderGeneral CounselSell10,000$30.00$300,000.00572View SEC Filing Icon  
9/20/2023Yong YuVPSell6,000$27.96$167,760.00106,135View SEC Filing Icon  
9/18/2023Aladar SzalayMajor ShareholderSell30,292$23.29$705,500.685,000View SEC Filing Icon  
9/18/2023John ThomasDirectorSell3,334$24.99$83,316.66475,793View SEC Filing Icon  
9/15/2023John ThomasDirectorSell3,333$21.90$72,992.70479,127View SEC Filing Icon  
9/15/2023Yong YuVPSell10,400$21.89$227,656.00106,135View SEC Filing Icon  
9/13/2023Aladar SzalayMajor ShareholderSell19,032$21.44$408,046.0860,568View SEC Filing Icon  
9/13/2023John W SmitherDirectorSell900$20.78$18,702.006,920View SEC Filing Icon  
9/13/2023Yong YuVPSell29,800$21.14$629,972.00106,135View SEC Filing Icon  
9/11/2023Aladar SzalayMajor ShareholderSell32,351$22.22$718,839.2299,865View SEC Filing Icon  
9/7/2023Aladar SzalayMajor ShareholderSell12,446$24.37$303,309.02157,047View SEC Filing Icon  
8/30/2023Yong YuVPSell19,800$24.70$489,060.00135,935View SEC Filing Icon  
8/18/2023Caroline JewettInsiderSell515$23.73$12,220.951,135View SEC Filing Icon  
8/18/2023Doug SamuelsonCFOSell1,297$23.73$30,777.812,303View SEC Filing Icon  
8/18/2023Joseph CappelloVPSell3,265$23.73$77,478.455,735View SEC Filing Icon  
8/18/2023Sean RyderGeneral CounselSell328$23.73$7,783.44572View SEC Filing Icon  
8/18/2023Thomas ZindrickCEOSell8,349$23.73$198,121.7714,651View SEC Filing Icon  
1/26/2023Qian ZhangVPBuy200$6.25$1,250.00200View SEC Filing Icon  
See Full Table
Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
CLICK HERE TO FIND OUT MORE

SEC Filings (Institutional Ownership Changes) for Genelux (NASDAQ:GNLX)

10.77% of Genelux stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GNLX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Genelux Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/21/2023California State Teachers Retirement System920$30K0.0%N/A0.004%Search for SEC Filing on Google Icon
8/15/2023Wells Fargo & Company MN3,678$0.12M0.0%+261.3%0.015%Search for SEC Filing on Google Icon
8/14/2023State Street Corp45,665$1.49M0.0%+493.1%0.185%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.142,799$4.67M0.0%+884.8%0.550%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC65,038$2.13M0.0%+72.5%0.250%Search for SEC Filing on Google Icon
8/11/2023JPMorgan Chase & Co.2,205$72K0.0%+2,105.0%0.008%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp32,737$1.07M0.0%+192.7%0.126%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.18,700$0.61M0.0%+23.2%0.072%Search for SEC Filing on Google Icon
8/10/2023Citigroup Inc.822$27K0.0%-72.9%0.003%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.1,332$44K0.0%N/A0.005%Search for SEC Filing on Google Icon
8/4/2023Atlas Private Wealth Advisors6,120$0.20M0.0%N/A0.024%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp9,354$0.31M0.0%N/A0.036%Search for SEC Filing on Google Icon
7/28/2023Hohimer Wealth Management LLC24,640$0.81M0.2%-45.2%0.095%Search for SEC Filing on Google Icon
7/20/2023Global Retirement Partners LLC2,500$82K0.0%N/A0.010%Search for SEC Filing on Google Icon
7/20/2023Exchange Traded Concepts LLC4,442$0.15M0.0%N/A0.018%Search for SEC Filing on Google Icon
7/17/2023Dubuque Bank & Trust Co.9,328$0.31M0.0%N/A0.038%Search for SEC Filing on Google Icon
7/14/2023LifeSteps Financial Inc.13,379$0.44M0.4%N/A0.054%Search for SEC Filing on Google Icon
7/10/2023AE Wealth Management LLC13,257$0.43M0.0%N/A0.054%Search for SEC Filing on Google Icon
5/16/2023State Street Corp7,700$0.21M0.0%N/A0.031%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC37,709$1.05M0.0%N/A0.154%Search for SEC Filing on Google Icon
5/12/2023BlackRock Inc.14,501$0.40M0.0%N/A0.059%Search for SEC Filing on Google Icon
5/12/2023Charles Schwab Investment Management Inc.15,176$0.42M0.0%N/A0.062%Search for SEC Filing on Google Icon
5/11/2023Citigroup Inc.3,031$84K0.0%N/A0.012%Search for SEC Filing on Google Icon
5/9/2023Tower Research Capital LLC TRC 1,147$32K0.0%N/A0.005%Search for SEC Filing on Google Icon
5/4/2023Barclays PLC33,178$0.92M0.0%N/A0.135%Search for SEC Filing on Google Icon
5/3/2023Axxcess Wealth Management LLC16,668$0.46M0.0%N/A0.068%Search for SEC Filing on Google Icon
5/3/2023Hohimer Wealth Management LLC44,940$1.25M0.4%N/A0.183%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Genelux logo
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.
Read More on Genelux

Today's Range

Now: $24.03
Low: $23.57
High: $24.89

50 Day Range

MA: $23.84
Low: $20.27
High: $29.98

52 Week Range

Now: $24.03
Low: $5.35
High: $40.98

Volume

59,267 shs

Average Volume

121,843 shs

Market Capitalization

$592.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Genelux?

Genelux's top insider shareholders include:
  1. Aladar Szalay (Major Shareholder)
  2. John Thomas (Director)
  3. Yong Yu (VP)
  4. Thomas Zindrick (CEO)
  5. John W Smither (Director)
  6. Joseph Cappello (VP)
  7. Doug Samuelson (CFO)
  8. Caroline Jewett (Insider)
  9. Sean Ryder (General Counsel)
  10. Qian Zhang (VP)
Learn More about top insider investors at Genelux.

Who are the major institutional investors of Genelux?

Genelux's top institutional investors include:
  1. BlackRock Inc. — 0.55%
  2. Geode Capital Management LLC — 0.25%
  3. State Street Corp — 0.19%
  4. Northern Trust Corp — 0.13%
  5. Hohimer Wealth Management LLC — 0.09%
  6. Charles Schwab Investment Management Inc. — 0.07%
Learn More about top institutional investors of Genelux stock.

Which institutional investors are selling Genelux stock?

In the last quarter, GNLX stock was sold by these institutional investors:
  1. Hohimer Wealth Management LLC
  2. Citigroup Inc.
In the previous year, company insiders that have sold Genelux company stock include:
  1. Aladar Szalay (Major Shareholder)
  2. John Thomas (Director)
  3. Yong Yu (VP)
  4. Thomas Zindrick (CEO)
  5. John W Smither (Director)
  6. Joseph Cappello (VP)
  7. Doug Samuelson (CFO)
  8. Caroline Jewett (Insider)
  9. Sean Ryder (General Counsel)
Learn More investors selling Genelux stock.

Which institutional investors are buying Genelux stock?

In the last quarter, GNLX stock was purchased by institutional investors including:
  1. BlackRock Inc.
  2. State Street Corp
  3. Geode Capital Management LLC
  4. Northern Trust Corp
  5. LifeSteps Financial Inc.
  6. AE Wealth Management LLC
  7. Bank of New York Mellon Corp
  8. Dubuque Bank & Trust Co.
Free Stock Analysis Report: Buy Sell Hold Predictions on Any Stock
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Analyze Any Stock Free